Back to Search Start Over

Can creatine supplementation form carcinogenic heterocyclic amines in humans?

Authors :
Pereira, Renato Tavares dos Santos
Dörr, Felipe Augusto
Pinto, Ernani
Solis, Marina Yazigi
Artioli, Guilherme Giannini
Fernandes, Alan Lins
Murai, Igor Hisashi
Dantas, Wagner Silva
Seguro, Antônio Carlos
Santinho, Mirela Aparecida Rodrigues
Roschel, Hamilton
Carpentier, Alain
Poortmans, Jacques Remi
Gualano, Bruno
Source :
Journal of Physiology. Sep2015, Vol. 593 Issue 17, p3959-3971. 13p.
Publication Year :
2015

Abstract

Key points There is a long-standing concern that creatine supplementation could be associated with cancer, possibly by facilitating the formation of carcinogenic heterocyclic amines (HCAs)., This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, does not cause a significant increase in HCA formation., HCAs detection was unrelated to creatine supplementation. Diet was likely to be the main factor responsible for HCAs formation after either placebo ( n = 6) or creatine supplementation ( n = 3)., These results directly challenge the recently suggested biological plausibility for the association between creatine use and risk of testicular germ cell cancer., Abstract Creatine supplementation has been associated with increased cancer risk. In fact, there is evidence indicating that creatine and/or creatinine are important precursors of carcinogenic heterocyclic amines (HCAs). The present study aimed to investigate the acute and chronic effects of low- and high-dose creatine supplementation on the production of HCAs in healthy humans (i.e. 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline (8-MeIQx), 2-amino-(1,6-dimethylfuro[3,2-e]imidazo[4,5-b])pyridine (IFP) and 2-amino-3,4,8-trimethylimidazo[4,5- f]quinoxaline (4,8-DiMeIQx)). This was a non-counterbalanced single-blind crossover study divided into two phases, in which low- and high-dose creatine protocols were tested. After acute (1 day) and chronic supplementation (30 days), the HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx were assessed through a newly developed HPLC-MS/MS method. Dietary HCA intake and blood and urinary creatinine were also evaluated. Out of 576 assessments performed (from 149 urine samples), only nine (3 from creatine and 6 from placebo) showed quantifiable levels of HCAs (8-MeIQx: n = 3; 4,8-DiMeIQx: n = 2; PhIP: n = 4). Individual analyses revealed that diet rather than creatine supplementation was the main responsible factor for HCA formation in these cases. This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, did not cause increases in the carcinogenic HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx in healthy subjects. These findings challenge the long-existing notion that creatine supplementation could potentially increase the risk of cancer by stimulating the formation of these mutagens. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00223751
Volume :
593
Issue :
17
Database :
Academic Search Index
Journal :
Journal of Physiology
Publication Type :
Academic Journal
Accession number :
109217174
Full Text :
https://doi.org/10.1113/JP270861